{"name": "Takeda Cambridge",
 "permalink": "takeda-cambridge",
 "crunchbase_url": "http://www.crunchbase.com/company/takeda-cambridge",
 "homepage_url": "http://takedacam.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "TCB",
 "email_address": "info@takedacam.com",
 "phone_number": "44-(0)1223-477910",
 "description": "",
 "created_at": "Fri Apr 23 05:51:40 UTC 2010",
 "updated_at": "Sat Jul 03 11:51:51 UTC 2010",
 "overview": "\u003Cp\u003ETakeda Cambridge Limited (TCB) and its subsidiary TSP, have established world-class target identification and validation capabilities. Together they have developed a promising pipeline of novel drug discovery targets and compounds in key areas of unmet medical need such as CNS disorders, chronic pain and urology indications, endocrinology and metabolic-related diseases.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[140,
       84],
      "assets/images/resized/0008/4680/84680v1-max-150x150.jpg"],
     [[140,
       84],
      "assets/images/resized/0008/4680/84680v1-max-250x250.jpg"],
     [[140,
       84],
      "assets/images/resized/0008/4680/84680v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$22.3M",
 "funding_rounds":
  [{"round_code": "d",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 12960000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 7,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Bio*One Capital",
         "permalink": "bio-one-capital",
         "image":
          {"available_sizes":
            [[[136,
               87],
              "assets/images/resized/0005/8067/58067v1-max-150x150.jpg"],
             [[136,
               87],
              "assets/images/resized/0005/8067/58067v1-max-250x250.jpg"],
             [[136,
               87],
              "assets/images/resized/0005/8067/58067v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Merlin Biosciences",
         "permalink": "merlin-biosciences",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Avlar BioVentures",
         "permalink": "avlar-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               71],
              "assets/images/resized/0008/3732/83732v1-max-150x150.jpg"],
             [[177,
               84],
              "assets/images/resized/0008/3732/83732v1-max-250x250.jpg"],
             [[177,
               84],
              "assets/images/resized/0008/3732/83732v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 9380000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 1,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Avlar BioVentures",
         "permalink": "avlar-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               71],
              "assets/images/resized/0008/3732/83732v1-max-150x150.jpg"],
             [[177,
               84],
              "assets/images/resized/0008/3732/83732v1-max-250x250.jpg"],
             [[177,
               84],
              "assets/images/resized/0008/3732/83732v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Merlin Biosciences",
         "permalink": "merlin-biosciences",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Bio*One Capital",
         "permalink": "bio-one-capital",
         "image":
          {"available_sizes":
            [[[136,
               87],
              "assets/images/resized/0005/8067/58067v1-max-150x150.jpg"],
             [[136,
               87],
              "assets/images/resized/0005/8067/58067v1-max-250x250.jpg"],
             [[136,
               87],
              "assets/images/resized/0005/8067/58067v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "418 Cambridge Science Park",
    "address2": "",
    "zip_code": "CB4 0PZ",
    "city": "Cambridge",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        122],
       "assets/images/resized/0008/4681/84681v1-max-150x150.jpg"],
      [[250,
        203],
       "assets/images/resized/0008/4681/84681v1-max-250x250.jpg"],
      [[450,
        366],
       "assets/images/resized/0008/4681/84681v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}